Contact Us
 • 
Home
Search 

Clinical Trials > RESILIENT  

  • Information
  • Sites - Interested
RESILIENT   

Title

RandomisEd, controlled, double blind Study to assess mechanistic effects of combination therapy of dapagliflozin with Exenatide QW versus dapagliflozin alone in obese (BMI>30 kg/m2) patients with Type 2 diabetes mellitus.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
IV Funded and in setup University of Liverpool

Trial Start Date

Trial Not Open


Trial Coordinator

Julie Perry


Trial Coordinator Email Address

jperry@liverpool.ac.uk


Trial Coordinator Contact No

0151 795 8577



UK: ENGLAND

  • , MARIARC (Graham Kemp)
  • Liverpool, University Hospital Aintree (Daniel Cuthbertson)